T helper cell (Th cell)

T helper cells (Th cells; CD4+ T cells) are a major subset of lymphocytes within the adaptive immune system, distinguished by their expression of the CD4 surface glycoprotein[1][5]. They coordinate and amplify the immune response by recognizing peptide antigens presented by major histocompatibility complex class II (MHC II) molecules on antigen-presenting cells and secreting cytokines that influence B cells, cytotoxic T lymphocytes (CD8+), macrophages, and other leukocytes[1][3][5]. They are crucial for antibody class switching, activation and memory formation of other immune cells, and overall orchestration of adaptive immunity[1][3][5][7]. Different functional subsets exist (Th1, Th2, Th17, Treg, Tfh, and others), each defined by unique cytokine profiles and immunoregulatory roles[3][5]. Th cells play central roles in numerous diseases, including infectious diseases, autoimmune disorders, cancers, and immunodeficiencies (notably, HIV infection causes progressive loss of CD4+ T cells)[5][7]. CD4+ T cells can display direct cytotoxic functions in some contexts and are the focus of emerging cell-therapy approaches, but as a population or “response” they are not a single drug target, receptor, nor enzyme, and thus not a canonical therapeutic molecular target[2][8]. Additional notes: - "CD4+ T cell response" refers to the collective functional activity of this cell population, not a singular molecular target. Attempts to modulate this "response" are immunomodulatory and not classically "targeting" a receptor or single molecule. - The CD4 molecule itself (CD4) is a recognized drug target (for example, targeted in HIV and some immunotherapies), but "CD4+ T cell response" denotes a functional property rather than a defined molecular structure suitable for structure-based drug targeting. - Drugs or antibodies directly targeting CD4 protein (e.g., anti-CD4 antibodies), or those broadly modulating the immune system (e.g., anti-CD3, checkpoint inhibitors, cytokines), may alter CD4+ T cell behavior, but not by interacting with a unique “CD4+ T cell response molecule.”

Other names

CD4+ T cellCD4-positive T cellHelper T cellT helper lymphocyte

Not applicable; drugs targeting CD4+ T cell response act via immune activation, suppression, or modulation